Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia

Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia

Not available.

Saved in:

Bibliographic Details
Main Authors:	Bradley Rockwell, Mendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, Yogen Saunthararajah, Kira Gritsman, Alejandro R. Sica, Noah Kornblum, Nishi Shah, David Levitz, Lauren C. Shapiro, Ridhi Gupta, Anne Munoz, Aradhika Dhawan, Karen Fehn, Monica Comas, Jhannine Verceles, Dennis L. Cooper, Marina Konopleva, Eric J. Feldman, Amit Verma
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-07-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/12177
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification
by: Rajvi Gor, et al.
Published: (2025-08-01)

Hematopoietic Stem Cell Transplant in Adult Patients with Fanconi Anemia: A Review
by: Bradley Rockwell, et al.
Published: (2025-06-01)

PPARγ-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AML
by: Kotoko Yamatani, et al.
Published: (2025-08-01)

Effective treatment of peritoneal myeloid sarcoma with decitabine and venetoclax: A case report
by: Kavya Sudireddy, et al.
Published: (2025-01-01)

Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS)
by: Heather Klocke, et al.
Published: (2020-01-01)

Epigenetic Reprogramming by Decitabine in Retinoblastoma
by: Lisa Gherardini, et al.
Published: (2025-04-01)

Metronomic chemotherapy in pediatric neuroblastoma
by: Yi Jiang, et al.
Published: (2024-12-01)

Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.
by: Robert Molokie, et al.
Published: (2017-09-01)

Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant
by: Leena T. Rahmat, et al.
Published: (2018-01-01)

Letter to the Editor for “Metronomic Chemotherapy in Pediatric Neuroblastoma”
by: Ana Ivanovski, et al.
Published: (2025-06-01)

Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports
by: Yunshuo Xiao, et al.
Published: (2024-12-01)

Mechanism of action of decitabine in treating acute lymphoblastic leukemia
by: Xiaohui Gao, et al.
Published: (2025-07-01)

Decitabine regulates the resistance of HCC to sorafenib through demethylation
by: Miao Zhang, et al.
Published: (2025-07-01)

Decitabine facilitates thrombopoiesis independent of the thrombopoietin receptor in zebrafish
by: Yudong Chen, et al.
Published: (2025-03-01)

Chronic myelomonocytic leukemia: A case report
by: Khevna Kansara, et al.
Published: (2024-10-01)

Acute Myelomonocytic Leukemia Presenting as Perianal Pain
by: Syma Iqbal, et al.
Published: (2018-01-01)

Metronomics in pediatric oncology: Lessons learned and the way forward
by: Raja Pramanik, et al.
Published: (2020-01-01)

Exploring new horizons in menin: it’s bleximenib’s turn
by: Bradley Rockwell, et al.
Published: (2025-03-01)

Splenic haemangiosarcoma in a cat treated with splenectomy and metronomic thalidomide
by: Victoria Coates, et al.
Published: (2025-08-01)

Successfully treatment of PLZF-RARα positive acute promyelocytic leukemia by Venetoclax combining with decitabine: a case report and literature review
by: Ziwei Zhou, et al.
Published: (2024-12-01)

Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy
by: Salvatore Russo, et al.
Published: (2024-03-01)

A drug repurposing screen identifies decitabine as an HSV-1 antiviral
by: Laura Bautista, et al.
Published: (2024-11-01)

A case of chronic myelomonocytic related lysozyme-induced nephropathy
by: Abhik Kansal, et al.
Published: (2025-07-01)

Chronic Myelomonocytic Leukemia Associated With TAFRO Syndrome-Like Symptoms
by: Issam Drici-Tani, et al.
Published: (2024-05-01)

Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemia
by: Juwita Werner, et al.
Published: (2025-04-01)

Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
by: Peter Rohon, et al.
Published: (2012-01-01)

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?
by: M. E. Cazzaniga, et al.
Published: (2017-01-01)

Metastatic primary angiosarcoma of the breast: Can we tame it the metronomic way
by: Raja Pramanik, et al.
Published: (2017-01-01)

The Relationship of Ludwig Van Beethoven and Johann Nepomuk Mälzel Through the Metronome
by: Göknil Özkök Sezener
Published: (2024-12-01)

Metronome-guided training accelerates the adaptation to an aerobic training pace in swimming
by: Marco Fassone, et al.
Published: (2025-05-01)

Metronomic photodynamic therapy for deep organ cancer by implantable wireless OLEDs
by: Yujiro Itazaki, et al.
Published: (2025-06-01)

La messagerie électronique, principal métronome des activités de cadre
by: Sophie Bretesché, et al.
Published: (2012-12-01)

Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors
by: Giorgia Anastasio, et al.
Published: (2025-02-01)

Case Report: Decitabine and venetoclax sequentially followed by FLAG-Ida and venetoclax with immediate allogeneic stem cell transplantation in newly diagnosed acute myeloid leukemia with chromosome 3 inversion/MECOM rearrangement
by: Andrius Žučenka, et al.
Published: (2025-03-01)

5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
by: Marianna Criscuolo, et al.
Published: (2011-01-01)

Diagnosis of acute myelomonocytic leukemia in a patient with extramedullary testicular lesion
by: N. K. Guskova, et al.
Published: (2022-11-01)

Posaconazole-Induced Adrenal Insufficiency in a Case of Chronic Myelomonocytic Leukemia
by: Ann Miller, et al.
Published: (2018-01-01)

5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
by: Mariangela Greco, et al.
Published: (2011-03-01)

Two distinct fetal‐type signatures characterize juvenile myelomonocytic leukemia
by: Marion Strullu, et al.
Published: (2025-03-01)

Juvenile Myelomonocytic Leukemia in a Premature Neonate Mimicking Neonatal Sepsis
by: Ming-Luen Lee, et al.
Published: (2016-04-01)